Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Basilea Pharmaceutica Ag (BPMUF)

Basilea Pharmaceutica Ag (BPMUF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Basilea Pharmaceutica Ag Hegenheimermattweg 167b Allschwil V8 4123 CHE

www.basilea.com Employees: 164 P: 41-61-606-1111

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

Basilea Pharmaceutica Ltd. is a commercial stage biopharmaceutical company developing products that address the medical challenge of increasing resistance and non-response to current treatment options in the therapeutic areas of bacterial infections, fungal infections and cancer. With two commercialized drugs, the company is committed to discovering, developing and commercializing innovative pharmaceutical products to meet the medical needs of patients with serious and life-threatening conditions.

Key Statistics

Overview:

Market Capitalization, $K 833,003
Enterprise Value, $K 691,513
Shares Outstanding, K 13,170
Annual Sales, $ 236,880 K
Annual Net Income, $ 88,140 K
EBIT, $ 0 K
EBITDA, $ 71,460 K
60-Month Beta 0.21
% of Institutional Shareholders 0.00%
Float, K 13,170
% Float 100.00%
Short Interest 7
Short Float 0.05%
Short Volume Ratio 1.00

Growth:

1-Year Return 27.69%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 75.14%
5-Year Earnings Growth 416.75%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 02/17/26
Earnings Per Share ttm 0.00
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

BPMUF Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward 14.04
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % 37.21%
Debt/Equity 0.00
Price/Sales 3.30
Price/Cash Flow 10.08
Price/Book 7.26
Book Value/Share 6.99
Interest Coverage 14.88
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar